Cabaletta Bio, Inc. (CABA)
2.91
-0.36
(-11.01%)
USD |
NASDAQ |
Sep 09, 16:00
2.96
+0.05
(+1.72%)
After-Hours: 05:41
Cabaletta Bio Total Assets (Quarterly) : 256.73M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 256.73M |
| March 31, 2026 | 148.15M |
| December 31, 2025 | 170.28M |
| September 30, 2025 | 189.76M |
| June 30, 2025 | 224.50M |
| March 31, 2025 | 165.14M |
| December 31, 2024 | 188.98M |
| September 30, 2024 | 204.41M |
| June 30, 2024 | 217.42M |
| March 31, 2024 | 240.46M |
| December 31, 2023 | 253.65M |
| September 30, 2023 | 173.29M |
| June 30, 2023 | 184.64M |
| March 31, 2023 | 103.45M |
| December 31, 2022 | 116.97M |
| September 30, 2022 | 91.68M |
| Date | Value |
|---|---|
| June 30, 2022 | 102.02M |
| March 31, 2022 | 113.66M |
| December 31, 2021 | 126.34M |
| September 30, 2021 | 122.64M |
| June 30, 2021 | 106.93M |
| March 31, 2021 | 107.28M |
| December 31, 2020 | 114.72M |
| September 30, 2020 | 121.77M |
| June 30, 2020 | 127.90M |
| March 31, 2020 | 134.96M |
| December 31, 2019 | 141.47M |
| September 30, 2019 | 74.94M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 34.17M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.14M |
| Shareholders Equity (Quarterly) | 210.59M |
| Debt to Equity Ratio | 0.1221 |
| Current Ratio | 5.789 |
| Net Debt Paydown Yield | 0.12% |